Tredu. Expert Education. Smarter Trading.

Mastering Equity and Stock Trading, Cryptocurrency Investment, Digital Assets and Global Forex Market Analysis: The Ultimate Masterclass at Tredu

Gain access to expert-led courses, live market analysis, and educational webinars that turn complex concepts into actionable strategies.Learn how to trade smarter and join our community of successful traders, building sustained financial growth.

Financial News

Maintain market dominance with real-time updates and expert analysis.
Our educators provide focused coverage across stock trading, forex markets, and crypto investing. We translate the latest financial news into practical knowledge, empowering you to trade smarter and achieve superior execution.

Proprietary Trading Strategies and
Quantitative Analysis

Sharpen your execution skills and gain a decisive edge with in-depth insights delivered by our top trading educators. Explore proven trading strategies, anticipate current market trends, and leverage expert analysis specifically designed to support your trading education and accelerate your path to sustained market success.

Tredu Team | Insights

Cisco Systems Inc. (NASDAQ:CSCO) Maintains "Buy" Rating Amidst Market Fluctuations

Cisco Systems Inc. (NASDAQ:CSCO) Maintains "Buy" Rating Amidst Market Fluctuations

Bank of America Securities reaffirms its "Buy" rating for Cisco Systems Inc. (NASDAQ:CSCO), signaling confidence in the company's future performance. The average brokerage recommendation (ABR) of 1.79 suggests a generally favorable outlook from Wall Street analysts, with a majority recommending Strong Buy or Buy. Cisco's current stock price of $76.21 reflects market volatility, yet the company's substantial market capitalization of $301.1 billion underscores its significant role in the tech industry. Cisco Systems Inc. (NASDAQ:CSCO) is a leading technology company known for its networking hardware, software, and telecommunications equipment. It competes with other tech giants like Juniper Networks and Arista Networks. On March 9, 2026, Bank of America Securities reiterated its "Buy" rating for Cisco, with the stock trading at $76.21 at the time. Wall Street analysts are optimistic about Cisco's future, as shown by its average brokerage recommendation (ABR) of 1.79. This rating, on a scale from 1 to 5, indicates a favorable outlook, falling between Strong Buy and Buy. Out of 26 brokerage firms, 15 have given Cisco a Strong Buy recommendation, while one has rated it as a Buy. These Strong Buy and Buy ratings make up over 61% of all recommendations, highlighting the positive sentiment from analysts. Such optimism can influence Cisco's stock price, as investors often consider these recommendations when making investment decisions. Currently, Cisco's stock price is $76.21, reflecting a decrease of 3.09% or $2.43. Today, the stock has traded between a low of $75.20 and a high of $77.56. Over the past year, the stock has reached a high of $88.19 and a low of $52.11. Cisco's market capitalization is approximately $301.1 billion, indicating its significant presence in the tech industry. The trading volume for the day is 31,373,993 shares on the NASDAQ exchange, showing active investor interest in the stock.

Tredu Team | Insights

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Faces Challenges Amidst Recent Clinical Study Results

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Faces Challenges Amidst Recent Clinical Study Results

Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is focused on developing targeted therapies for women's cancers, with collaborations with Pfizer Inc. and Novartis AG. Despite a recent price target of $38 by H.C. Wainwright, Olema's stock has declined to $16.30, influenced by disappointing results from Roche Holdings AG's phase 3 persevERA Breast Cancer study. Olema's stock shows significant volatility, with a year's trading range between $2.86 and $36.26, and a market capitalization of approximately $1.28 billion. Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is a biopharmaceutical company dedicated to the development of targeted therapies for women's cancers, particularly breast cancer. The company's leading project, Palazestrant, represents a new class of treatments as a complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD). Olema's strategic collaborations with pharmaceutical giants like Pfizer Inc. and Novartis AG underscore its commitment to advancing its clinical trials. On March 9, 2026, Emily Bodnar from H.C. Wainwright set a price target of $38 for OLMA, indicating a potential upside of approximately 69% from its then-current trading price of $16.45. However, the stock has recently faced a downturn, now trading at $16.30, marking a decrease of 24.36% with a change of $5.25. This decline is attributed to recent data from Roche Holdings AG's phase 3 persevERA Breast Cancer study, which did not meet its primary endpoint of demonstrating a statistically significant improvement in progression-free survival. The study's outcome has adversely affected Olema's stock, given the similarity between Roche's giredestrant and Olema's Palazestrant. Despite these challenges, Olema's stock has experienced significant fluctuations, with a daily low of $12.99 and a high of $18.62. Over the past year, the stock has ranged from a low of $2.86 to a high of $36.26, highlighting its volatile nature. With a market capitalization of approximately $1.28 billion and a trading volume of 11.89 million shares today, Olema continues to attract active investor interest despite recent setbacks.

Tredu Team | Insights

City Holding Company (NASDAQ:CHCO) Sees Insider Buying Amidst Varied Investor Sentiment

City Holding Company (NASDAQ:CHCO) Sees Insider Buying Amidst Varied Investor Sentiment

Director Robert D. Fisher's purchase of 213 shares indicates confidence in NASDAQ:CHCO's future. Citigroup Inc. reduces its stake in CHCO by 23.2%, contrasting with Fisher's optimistic view. Royal Bank of Canada and AQR Capital Management LLC increase their holdings, showing varied investor sentiment towards CHCO. City Holding Company (NASDAQ:CHCO) is a financial institution that provides a range of banking services. It operates primarily in the United States, offering services such as personal banking, business banking, and wealth management. The company competes with other financial institutions like Citigroup and Royal Bank of Canada. On March 9, 2026, Robert D. Fisher, a director at CHCO, purchased 213 shares of the company's common stock at $115.88 each. This transaction increased his total ownership to approximately 46,978 shares. This move by Fisher indicates confidence in the company's future prospects, despite the stock's recent price decrease of about 1.75% or $2.06. Citigroup Inc. has reduced its stake in CHCO by 23.2% during the recent quarter, selling 4,638 shares. This adjustment leaves Citigroup with 15,379 shares, representing a 0.11% ownership in the company, valued at approximately $1.9 million. This reduction contrasts with Fisher's purchase, highlighting differing perspectives on the stock's potential. Meanwhile, other investors have shown increased interest in CHCO. The Royal Bank of Canada increased its stake by 5.6%, acquiring an additional 821 shares, bringing its total to 15,586 shares valued at around $1.8 million. AQR Capital Management LLC also expanded its holdings by 34.5%, purchasing 2,305 more shares to own a total of 8,977 shares, worth about $1.1 million. CHCO's current stock price is approximately $115.93, with a market capitalization of around $1.67 billion. The stock has fluctuated between a low of $113.52 and a high of $116.47 during the trading day. Over the past year, it has reached a high of $133.59 and a low of $102.22, reflecting the volatility in the market.

Connect with Verified Trading
Educators for Tailored Mentorship
Across All Trading Styles

ADVANCED SEARCH

108 results

Top Brokers

Secure Your Trading Journey with the Right Broker

Advertisement for tredu.com - trading platform

Proud Media Partners of

Cyprus Fintech SummitMoney ExpoGlobal AI Show Abu DhabiGlobal Games ShowForex Expo DubaiGlobal Blockchain ShowEuropean Blockchain ConventionCyprus Fintech SummitMoney ExpoGlobal Games ShowFinancial Innovation ForumGlobal AI Show Abu DhabiForex Expo DubaiGlobal Games ShowCyprus Fintech SummitMoney ExpoGlobal Blockchain ShowEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation ForumForex Expo DubaiGlobal Blockchain ShowCyprus Fintech SummitMoney ExpoEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation ForumCyprus Fintech SummitMoney ExpoGlobal AI Show Abu DhabiGlobal Games ShowForex Expo DubaiGlobal Blockchain ShowEuropean Blockchain ConventionCyprus Fintech SummitMoney ExpoGlobal Games ShowFinancial Innovation ForumGlobal AI Show Abu DhabiForex Expo DubaiGlobal Games ShowCyprus Fintech SummitMoney ExpoGlobal Blockchain ShowEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation ForumForex Expo DubaiGlobal Blockchain ShowCyprus Fintech SummitMoney ExpoEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation Forum